“Digitizing images in pathology has the potential to transform the field by unlocking new opportunities in image recognition,” said Philips digital pathology solutions general manager Russ Granzow. Massachusetts-based disease diagnosis start-up PathAI has secured $60m in a series B funding round led by growth equity company General Atlantic. The new funding, which was announced on Monday, will be used to expand the company’s clinical trial and development efforts into other areas of health care, including cancer care. By offering faster, cheaper and safer sub-typing of diseases like breast cancer, PathAI plans to carve out a market share in the health care cloud computing sector, which is set to be worth $35bn. The new finance follows an earlier $11m series A funding round, and brings its total venture capital raised to $75m.
Massachusetts-based disease diagnosis start-up PathAI has secured $60m in a series B funding round led by growth equity company General Atlantic. The new funding, which was announced on Monday, will be used to expand the company’s clinical trial and development efforts into other areas of health care, including cancer care. By offering faster, cheaper and safer sub-typing of diseases like breast cancer, PathAI plans to carve out a market share in the health care cloud computing sector, which is set to be worth $35bn. The new finance follows an earlier $11m series A funding round, and brings its total venture capital raised to $75m.